Cancer
JACKSONVILLE, Fla. — Mayo Clinic researchers have developed an experimental drug with the help of artificial intelligence (AI) to target the "undruggable" PDZ-domain of GIPC1[...]
Latest stories
Cardiovascular
September 4, 2025
Discovery Science
September 3, 2025
Featured News
August 18, 2025
Research
August 5, 2025
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community